Categorized | Stock Newsletters

Lebed.biz Alert – MDLH planning to target diabetes market!

Medical International Technology Inc (MDLH) is planning to use their needle-free injectors to target the diabetes market!
 
MDLH just announced on Monday that it will be targeting the huge diabetes market with their newly developed Med-Jet model MIT-P-I within the next 8 to 10 months.
 
The diagnosis rate of diabetes has increased over the last two decades from 30 million to 246 million people with a disproportionate ratio coming from the United States, India, and China.
 
Think about the millions of people around the world with diabetes who must inject themselves with insulin daily. MDLH's needle-free injection technology allows for painless injections and reduces the damage to skin and tissues!
 
MDLH intends to introduce this product in China first through their Chinese joint venture!
 
MDLH also plans to target the dentistry market with their Med-Jet model MIT-H-VI within the next 12 to 16 month. In the dental office, painful needle injections are enough to make even the most rational person skip dental visits. MDLH's Med-Jet MIT-H-VI could finally bring an end to traumatic dental visits.
 
MDLH is providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet and Agro-Jet needle-free injection system!
 
-----
 
My firm Lebed Biz LLC has been compensated by a third-party (Wall Street Grand, LLC) $20,000 cash for a one-month MDLH investor relations contract. Never invest into a stock we discuss unless you can afford to lose your entire investment. For our full disclaimer go to:
www.lebed.biz/disclaimer.htm
 
Jonathan Lebed
Lebed.biz
Staff


This message was sent from Jonathan Lebed to Subscriber. It was sent from: Jonathan Lebed, 350 Ramapo Valley Rd, Oakland, NJ 07436. You can modify/update your subscription via the link below.

Email Marketing by
iContact - Try It Free!


 

Leave a Reply